$7.93 Billion is the total value of Paulson & Co.'s 103 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CACQ | CAESARS ACQUISITION COcl a | $177,093,000 | +8.7% | 13,117,998 | 0.0% | 2.23% | +26.4% | |
| AU | ANGLOGOLD ASHANTI LTDsponsored adr | $134,343,000 | -34.0% | 12,782,400 | 0.0% | 1.69% | -23.3% | |
| RLGY | REALOGY HLDGS CORP | $123,118,000 | -0.5% | 4,785,000 | 0.0% | 1.55% | +15.7% | |
| CZR | CAESARS ENTMT CORP | $122,552,000 | +14.1% | 14,417,900 | 0.0% | 1.54% | +32.7% | |
| WLH | LYON WILLIAM HOMEScl a new | $63,230,000 | +2.6% | 3,322,666 | 0.0% | 0.80% | +19.3% | |
| COBALT INTL ENERGY INCnote 3.125% 5/1 | $61,384,000 | -26.3% | 219,229,000 | 0.0% | 0.77% | -14.3% | ||
| AGN | ALLERGAN PLCcall | $45,089,000 | -8.8% | 214,700 | 0.0% | 0.57% | +6.0% | |
| GOLD | RANDGOLD RES LTDadr | $38,170,000 | -23.7% | 500,000 | 0.0% | 0.48% | -11.3% | |
| ENZY | ENZYMOTEC LTD | $27,549,000 | -6.4% | 4,205,980 | 0.0% | 0.35% | +8.8% | |
| IAG | IAMGOLD CORP | $14,876,000 | -4.9% | 3,863,912 | 0.0% | 0.19% | +10.0% | |
| SYMX | SYNTHESIS ENERGY SYS INC | $10,000,000 | -17.4% | 10,000,000 | 0.0% | 0.13% | -3.8% | |
| FCH | FELCOR LODGING TR INC | $4,005,000 | +24.6% | 500,000 | 0.0% | 0.05% | +42.9% | |
| KMDA | KAMADA LTD | $3,983,000 | +6.2% | 730,800 | 0.0% | 0.05% | +22.0% | |
| CBOE | CBOE HLDGS INC | $2,838,000 | +13.9% | 38,412 | 0.0% | 0.04% | +33.3% | |
| INSM | INSMED INC | $2,715,000 | -8.9% | 205,200 | 0.0% | 0.03% | +6.2% | |
| WCIC | WCI CMNTYS INC | $1,642,000 | -1.1% | 70,000 | 0.0% | 0.02% | +16.7% | |
| ALDR | ALDER BIOPHARMACEUTICALS INC | $1,539,000 | -36.5% | 74,000 | 0.0% | 0.02% | -26.9% | |
| ESPR | ESPERION THERAPEUTICS INC NE | $1,277,000 | -9.6% | 102,000 | 0.0% | 0.02% | +6.7% | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $687,000 | -62.4% | 174,000 | 0.0% | 0.01% | -55.0% | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | $723,000 | -44.7% | 19,300 | 0.0% | 0.01% | -35.7% | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | $251,000 | -12.2% | 70,800 | 0.0% | 0.00% | 0.0% | |
| LILA | LIBERTY GLOBAL PLC | $110,000 | -20.3% | 4,990 | 0.0% | 0.00% | 0.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-02-14
About Paulson & Co.
Paulson & Co. is a New York-based investment management firm founded by John Paulson in 1994. The firm is known for its expertise in event-driven investing, which involves taking advantage of market inefficiencies created by corporate events such as mergers, acquisitions, bankruptcies, and spin-offs. Paulson & Co. manages approximately $9 billion in assets and has a team of over 100 professionals.
John Paulson, the founder and CEO of Paulson & Co., is a renowned hedge fund manager who made a fortune by betting against the subprime mortgage market in 2007. He is considered one of the most successful investors of his generation, with a net worth of over $4 billion. Paulson is actively involved in the management of the firm and oversees the investment strategy.
Paulson & Co. has a strong track record of generating high returns for its investors. The firm's flagship fund, the Paulson Advantage Fund, has delivered an average annual return of 12.5% since its inception in 1994. The fund has also outperformed the S&P 500 index in 16 out of the past 22 years.
In recent years, Paulson & Co. has faced some challenges, including a decline in assets under management and a series of high-profile losses. However, the firm has remained committed to its investment philosophy and has continued to generate strong returns for its investors. With a talented team of professionals and a proven track record of success, Paulson & Co. is well-positioned to continue delivering value to its clients in the years ahead.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NOVAGOLD RESOURCES INC | 42 | Q3 2023 | 12.0% |
| INTERNATIONAL TOWER HILL MINE | 42 | Q3 2023 | 3.4% |
| IAMGOLD CORP | 42 | Q3 2023 | 0.5% |
| ANGLOGOLD ASHANTI-SPON ADR | 41 | Q2 2023 | 7.9% |
| AGNICO EAGLE MINES LTD | 34 | Q3 2023 | 3.8% |
| SPDR GOLD TRUST | 33 | Q1 2022 | 13.3% |
| TRILOGY METALS INC NEW | 29 | Q3 2023 | 0.9% |
| ENDO INTL PLC | 28 | Q2 2022 | 3.4% |
| CAESARS ENTMT CORP | 27 | Q4 2019 | 4.6% |
| TIM PARTICIPACOES SA-ADR | 26 | Q3 2020 | 2.4% |
View Paulson & Co.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Thryv Holdings, Inc. | February 14, 2023 | 2,000,000 | 5.8% |
| Endo International plc | February 14, 2022 | 17,327,012 | 7.4% |
| BrightSphere Investment Group Inc. | December 22, 2021 | 8,950,121 | 19.8% |
| PERPETUA RESOURCES CORP. | August 27, 2021 | 20,929,280 | 33.3% |
| Bausch Health Companies Inc. | May 15, 2020 | 25,839,035 | 7.3% |
| OVERSEAS SHIPHOLDING GROUP INC | April 13, 2020 | 6,300,000 | 7.3% |
| SYNTHESIS ENERGY SYSTEMS INC | February 14, 2020 | 165,648 | 10.5% |
| Callon Petroleum Co | November 18, 2019 | 10,338,663 | 4.5% |
| International Seaways, Inc. | July 03, 2019 | 1,459,119 | 5.0% |
| AKORN INCSold out | February 14, 2018 | 0 | 0.0% |
View Paulson & Co.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-01-22 |
| SC 13D/A | 2024-01-22 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-11-13 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
View Paulson & Co.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.